Novartis AG (JOBS) to Buy Generic Cancer Drugs for $1.2 Billion from EBEWE Pharma
Reuters -- Novartis AG is buying the injectable generic cancer drugs business of Austria's EBEWE Pharma and may pursue other similar deals as it fleshes out a planned diversification away from brand-name treatments.